Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 61.82 K53.82 K79.15 K32.29 K8 50789.61 K 209.56 K Research & development —————— — Operating income -61.82 K-76.43 K-239.4 K-1.51 M-698.88 K-898.77 K -3.34 M Non-Operating Income, Total 30321.85 K2.12 M1.97 M1.81 M1.84 M 7.74 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 30321.85 K2.12 M1.97 M1.81 M1.84 M 7.74 M Unusual income/expense —————— — Pretax income -61.79 K245.41 K1.88 M468.69 K1.11 M940.44 K 4.4 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -61.79 K245.41 K1.88 M468.69 K1.11 M940.44 K 4.4 M Discontinued operations —————— — Net income -61.79 K245.41 K1.88 M468.69 K1.11 M940.44 K 4.4 M Dilution adjustment 00000— — Preferred dividends 223.73 M201.57 M-2.11 M-225.69 M1.81 M— — Diluted net income available to common stockholders -223.79 M-201.33 M3.99 M226.16 M-694.03 K940.44 K 230.39 M Basic earnings per share (Basic EPS) 0.93.67-3.58-0.320.030.03 -3.84 Diluted earnings per share (Diluted EPS) 0.93.67-3.58-0.320.030.03 -3.84 Average basic shares outstanding 6.15 M8.41 M16.13 M19.48 M27.96 M27.96 M — Diluted shares outstanding 6.15 M16.83 M32.26 M38.96 M55.92 M27.96 M — EBITDA —————— — EBIT -61.79 K-75.72 K-227.05 K-1.5 M-694.03 K-895.79 K -3.31 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —